Actively Recruiting
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Led by Sanofi · Updated on 2026-04-13
180
Participants Needed
79
Research Sites
364 weeks
Total Duration
On this page
Sponsors
S
Sanofi
Lead Sponsor
M
Meiji Seika Pharma Co., Ltd.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This double-blind, randomized, placebo-controlled, multinational, multicenter, parallel-group, Phase 3, 2-arm, study will investigate the efficacy and safety of belumosudil compared with placebo, both administered on top of azithromycin and standard-of-care regimen of immunosuppression in male or female participants at least 1 year after bilateral lung transplant, who are at least 18 years of age and who have evidence of progressive CLAD despite azithromycin therapy. Study details include: The study duration will be up to 31 weeks for participants not entering the open-label extension (OLE) period and up to 57 weeks for participants entering the OLE period but not the long-term OLE. The treatment duration will be up to 26 weeks for participants not entering the OLE period and up to 52 weeks for participants entering the OLE period but not the long-term OLE. The number of visits will be up to 10 visits for participants not entering the OLE period and up to 16 visits for participants entering the OLE period but not the long-term OLE. For participants who enter the long-term OLE, treatment and study participation will continue with visits every 12 weeks per protocol specifications.
CONDITIONS
Official Title
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant is at least 1 year post bilateral lung transplantation at screening
- Participants have CLAD Stage 1 or 2 with FEV1 between greater than 50% to 80% of post-transplant baseline at screening and randomization
- Participants have received at least 8 weeks of azithromycin at 250 mg/day or more, at least 3 times a week, prior to randomization
You will not qualify if you...
- FEV1 is 50% or less of the post-transplant baseline value (CLAD stages 3 and 4)
- Lung function decline caused by non-CLAD reasons such as acute lung allograft rejection (greater than A1), antibody-mediated rejection, airway stenosis, or tracheobronchomalacia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 79 locations
1
University of Alabama at Birmingham- Site Number : 8400026
Birmingham, Alabama, United States, 35233
Actively Recruiting
2
St. Joseph's Hospital and Medical Center- Site Number : 8400019
Phoenix, Arizona, United States, 85013
Actively Recruiting
3
University of California Los Angeles Medical Center- Site Number : 8400020
Los Angeles, California, United States, 90095
Actively Recruiting
4
Stanford University Medical Center- Site Number : 8400008
Stanford, California, United States, 94305
Actively Recruiting
5
Mayo Clinic in Florida- Site Number : 8400031
Jacksonville, Florida, United States, 32224
Actively Recruiting
6
Jackson Memorial Hospital- Site Number : 8400030
Miami, Florida, United States, 33136
Actively Recruiting
7
AdventHealth Orlando- Site Number : 8400023
Orlando, Florida, United States, 32803
Actively Recruiting
8
Tampa General Hospital - Tampa - General Circle- Site Number : 8400015
Tampa, Florida, United States, 33606
Actively Recruiting
9
Emory University Hospital- Site Number : 8400027
Atlanta, Georgia, United States, 30324
Actively Recruiting
10
Northwestern University- Site Number : 8400003
Chicago, Illinois, United States, 60611
Actively Recruiting
11
Loyola University Medical Center- Site Number : 8400025
Maywood, Illinois, United States, 60153
Actively Recruiting
12
University of Iowa- Site Number : 8400032
Iowa City, Iowa, United States, 52242
Actively Recruiting
13
University of Maryland School of Medicine - Baltimore- Site Number : 8400009
Baltimore, Maryland, United States, 21201
Actively Recruiting
14
Johns Hopkins Hospital- Site Number : 8400034
Baltimore, Maryland, United States, 21287
Actively Recruiting
15
University of Michigan Health System - Ann Arbor- Site Number : 8400014
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
16
Corewell Health - Grand Rapids - Michigan Street Northeast- Site Number : 8400010
Grand Rapids, Michigan, United States, 49503
Actively Recruiting
17
NYU Perlmutter Cancer Center - Energy Building- Site Number : 8400001
New York, New York, United States, 10016
Actively Recruiting
18
Icahn School of Medicine at Mount Sinai- Site Number : 8400037
New York, New York, United States, 10029
Actively Recruiting
19
Columbia University Irving Medical Center- Site Number : 8400002
New York, New York, United States, 10032
Actively Recruiting
20
Montefiore Medical Center - Moses Campus- Site Number : 8400036
The Bronx, New York, United States, 10467
Actively Recruiting
21
Duke University Medical Center- Site Number : 8400017
Durham, North Carolina, United States, 27710
Actively Recruiting
22
Cleveland Clinic - Cleveland- Site Number : 8400005
Cleveland, Ohio, United States, 44195
Actively Recruiting
23
The Ohio State University- Site Number : 8400028
Columbus, Ohio, United States, 43210
Actively Recruiting
24
Penn Medicine: University of Pennsylvania Health System- Site Number : 8400006
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
25
Temple University Hospital- Site Number : 8400007
Philadelphia, Pennsylvania, United States, 19140
Actively Recruiting
26
Vanderbilt University Medical Center- Site Number : 8400018
Nashville, Tennessee, United States, 37232
Actively Recruiting
27
University of Texas - Southwestern Medical Center- Site Number : 8400013
Dallas, Texas, United States, 75390
Actively Recruiting
28
Baylor College of Medicine- Site Number : 8400024
Houston, Texas, United States, 77030
Actively Recruiting
29
Houston Methodist Hospital- Site Number : 8400021
Houston, Texas, United States, 77030
Actively Recruiting
30
University Health System - San Antonio- Site Number : 8400035
San Antonio, Texas, United States, 78229
Actively Recruiting
31
Inova Fairfax Hospital- Site Number : 8400004
Falls Church, Virginia, United States, 22042
Actively Recruiting
32
Investigational Site Number : 0360003
Darlinghurst, New South Wales, Australia, 2010
Actively Recruiting
33
Investigational Site Number : 0360001
Brisbane, Queensland, Australia, 4032
Actively Recruiting
34
Investigational Site Number : 0360002
Murdoch, Western Australia, Australia, 6150
Actively Recruiting
35
Investigational Site Number : 0400001
Vienna, Austria, 1090
Actively Recruiting
36
Investigational Site Number : 0560001
Leuven, Belgium, 3000
Actively Recruiting
37
Investigational Site Number : 0560002
Yvoir, Belgium, 5530
Actively Recruiting
38
Investigational Site Number : 1240002
Edmonton, Alberta, Canada, T6G 2B7
Actively Recruiting
39
Investigational Site Number : 1240001
Vancouver, British Columbia, Canada, V5Z 1M9
Actively Recruiting
40
Investigational Site Number : 1240004
Toronto, Ontario, Canada, M5G 2C4
Actively Recruiting
41
Investigational Site Number : 1560004
Beijing, China, 100029
Actively Recruiting
42
Investigational Site Number : 1560002
Chengdu, China, 610072
Actively Recruiting
43
Investigational Site Number : 1560008
Fuzhou, China, 350001
Actively Recruiting
44
Investigational Site Number : 1560007
Guangzhou, China, 510163
Actively Recruiting
45
Investigational Site Number : 1560001
Hangzhou, China, 310009
Actively Recruiting
46
Investigational Site Number : 1560005
Hefei, China, 230001
Actively Recruiting
47
Investigational Site Number : 1560009
Shanghai, China, 200433
Actively Recruiting
48
Investigational Site Number : 1560003
Wuxi, China, 214023
Actively Recruiting
49
Investigational Site Number : 1560006
Zhengzhou, China, 450052
Actively Recruiting
50
Investigational Site Number : 2030002
Olomouc, Czechia, 779 00
Actively Recruiting
51
Investigational Site Number : 2030001
Prague, Czechia, 150 06
Actively Recruiting
52
Investigational Site Number : 2080001
Copenhagen, Denmark, 2100
Actively Recruiting
53
Investigational Site Number : 2460001
Helsinki, Finland, 00290
Actively Recruiting
54
Investigational Site Number : 2500005
Le Plessis-Robinson, France, 92350
Actively Recruiting
55
Investigational Site Number : 2500006
Marseille, France, 13915
Actively Recruiting
56
Investigational Site Number : 2500002
Pessac, France, 33604
Actively Recruiting
57
Investigational Site Number : 2500003
Saint-Herblain, France, 44800
Actively Recruiting
58
Investigational Site Number : 2500001
Suresnes, France, 92151
Actively Recruiting
59
Investigational Site Number : 2760003
Munich, Germany, 81337
Actively Recruiting
60
Investigational Site Number : 3480001
Budapest, Hungary, 1085
Actively Recruiting
61
Investigational Site Number : 2500004
Mumbai, India, 400026
Actively Recruiting
62
Investigational Site Number : 3760001
Petah Tikva, Israel, 4941492
Actively Recruiting
63
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano-Site Number : 3800001
Milan, Milano, Italy, 20122
Actively Recruiting
64
Investigational Site Number : 3800005
Padua, Padova, Italy, 35128
Actively Recruiting
65
IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione)-Site Number : 3800004
Palermo, Italy, 90127
Actively Recruiting
66
Fondazione IRCCS Policlinico San Matteo-Site Number : 3800003
Pavia, Italy, 27100
Actively Recruiting
67
Azienda Ospedaliera Universitaria Senese UOC Malattie Respiratorie e Trapianto Polmonare-Site Number : 3800002
Siena, Italy, 53100
Actively Recruiting
68
Brigham & Women's Hospital- Site Number : 8400016
Joso-Shi, Massachusetts, Japan, 3030005
Actively Recruiting
69
Investigational Site Number : 5280001
Groningen, Netherlands, 9713 GR
Actively Recruiting
70
Investigational Site Number : 5780001
Oslo, Norway, 0372
Actively Recruiting
71
Investigational Site Number : 4100004
Yangsan, Gyeongsangnam-do, South Korea, 50612
Actively Recruiting
72
Investigational Site Number : 4100002
Seoul, Seoul-teukbyeolsi, South Korea, 03080
Actively Recruiting
73
Investigational Site Number : 4100001
Seoul, Seoul-teukbyeolsi, South Korea, 03722
Actively Recruiting
74
Investigational Site Number : 4100003
Seoul, Seoul-teukbyeolsi, South Korea, 06351
Actively Recruiting
75
Investigational Site Number : 7240002
A Coruña, A Coruña [La Coruña], Spain, 15006
Actively Recruiting
76
Investigational Site Number : 7240003
Barcelona, Barcelona [Barcelona], Spain, 08035
Actively Recruiting
77
Investigational Site Number : 7240001
Santander, Cantabria, Spain, 39008
Actively Recruiting
78
Investigational Site Number : 7240004
Valencia, Spain, 46026
Actively Recruiting
79
Investigational Site Number : 7520001
Gothenburg, Sweden, 413 45
Actively Recruiting
Research Team
T
Trial Transparency email recommended (Toll free number for US & Canada)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here